Search

for
Search:

GlossaryCutaneous T-Cell Lymphoma (CTCL)

rare skin cancer involving malignant T-cells

Cutaneous T-Cell Lymphoma (CTCL) is a rare type of non-Hodgkin lymphoma that primarily affects the skin. It involves malignant T-cells, a type of white blood cell, which accumulate in the skin and cause symptoms such as red, scaly patches, plaques, or tumors.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 113 results

research Cutaneous T-Cell Lymphoma Outcomes During COVID-19

September 2021 in “Journal of the American Academy of Dermatology”

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

research Correlation Between Clinical, Histopathological, and Direct Immunofluorescence Findings in Cases of Cicatricial Alopecias

1 citations , November 2016 in “International Journal of Research in Dermatology”

The study found no significant link between the symptoms, tissue analysis, and immunofluorescence results in scarring hair loss conditions.

research Alopecias Due to Drugs and Other Skin and Systemic Disorders

7 citations , January 2015 in “Current problems in dermatology”

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

research Hypopigmented Mycosis Fungoides Progressing to Systemic Involvement: A Case Report and Review of Literature

September 2017 in “Journal of Investigative Dermatology Symposium Proceedings”

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

research Immunomodulators in the Treatment of Cutaneous Lymphoma

11 citations , September 1999 in “Journal of the European Academy of Dermatology and Venereology”

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

View more "ctcl" in research →

Community Join

0 / 0 results

— no results